statistiche ricercatore

Nome	#
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication.	59
Hepatic arterial embolization in patients with neuroendocrine tumors.	55
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors	40
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib	39
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study	38
Insulin resistance and acne: a new risk factor for men?	37
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors	36
Limitations of Chromogranin A in clinical practice.	35
Thyroid function in Fabry disease before and after enzyme replacement therapy.	35
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1	35
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1	34
Role of Metformin on Recurrence-Free Survival in Neuroendocrine Tumors	19
Totale	462

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	3	0	0	0	0	0	0	0	0	0	1	1	1
2019/2020	38	15	0	2	0	2	0	0	0	0	7	8	4
2020/2021	21	0	2	2	2	2	7	2	0	2	0	2	0
2021/2022	87	1	0	0	0	0	3	0	0	18	8	29	28
2022/2023	172	13	25	3	21	22	22	2	13	23	23	5	0
2023/2024	80	4	14	5	5	6	13	14	18	0	1	0	0
Totale													462